Physician profile
Laurel Jensen
NPI 1801947486
$3,188.22
in general payments reported to CMS, 2019-2025
22 companies · $521 in 2025
The $521 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $172 · 2021: $544 · 2022: $581 · 2023: $686 · 2024: $424 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,486 · Entertainment: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,486.14 |
| Entertainment | $144.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $465.57 | 2022-2025 | |
| Kala Pharmaceuticals, INC. | $413.67 | 2021-2022 | |
| Glaukos Corporation | $367.45 | 2021-2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished), Photrexa Cross-Linking Kit |
| Rxsight INC | $227.66 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Coopervision INC. | $207.74 | 2021-2024 | Misight Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $195.13 | 2019-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $187.13 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $184.40 | 2020-2025 | Cequa |
| Optos, INC. | $144.65 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Sight Sciences, INC. | $138.25 | 2021-2023 | Tearcare System |
| Bausch & Lomb Americas INC. | $124.99 | 2023 | Revive |
| Johnson & Johnson Surgical Vision, INC. | $116.85 | 2019 | |
| Alcon Vision LLC | $94.76 | 2019-2023 | Wavelight Refractive Suite |
| International Rehabilitative Sciences, INC | $61.35 | 2023 | Rs 4i Plus Sequential Stimulator |
| Harrow Eye, LLC | $58.42 | 2024-2025 | Vevye |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $57.23 | 2024 | Omidria |
| Visioneering Technologies, INC. | $38.65 | 2023 | |
| Lkc Technologies, INC. | $27.13 | 2024 | |
| Visionix USA, INC | $26.40 | 2024 | Ifusion |
| Oyster Point Pharma, INC. | $20.81 | 2024 | Tyrvaya |
| Dompe US, INC. | $16.02 | 2024 | Oxervate |
| Amgen INC. | $13.96 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurel Jensen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.